Noveome Biotherapeutics, Inc. — Form D/A

Noveome Biotherapeutics, Inc. of PITTSBURGH, PA, a company, filed a Form D amendment with the SEC on 2016-04-14. The offering totals $2.5M, of which $2.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
A. Clarke AtwellDirectorPITTSBURGH, PA
A. Clarke AtwellExecutive OfficerPITTSBURGH, PA
William GoldenDirectorPittsburgh, PA
William GoldenExecutive OfficerPittsburgh, PA
William GoldenRelated PersonPittsburgh, PA
Michael KaufmanDirectorBeachwood, OH
Robert LangerDirectorPittsburgh, PA
Robert LangerRelated PersonPittsburgh, PA
Houman HemmatiDirectorBeachwood, OH
Craig NemiroffDirectorBeachwood, OH
Eric KellerDirectorMcLean, VA
Patrick WelchDirectorPittsburgh, PA
Patrick WelchExecutive OfficerPittsburgh, PA
Patrick WelchRelated PersonPittsburgh, PA
Ronald PoropatichDirectorPittsburgh, PA
Gretchen KraemerExecutive OfficerPittsburgh, PA
Patric WelchDirectorPittsburgh, PA
Patric WelchExecutive OfficerPittsburgh, PA
Terence GoldenDirectorPittsburgh, PA
Terence GoldenRelated PersonPittsburgh, PA
Donald WagnerDirectorPittsburgh, PA
Donald WagnerRelated PersonPittsburgh, PA
John McArthurDirectorPittsburgh, PA
John McArthurRelated PersonPittsburgh, PA
George SingDirectorPITTSBURGH, PA

Other filings by this issuer (7)

FiledFormOfferingSold
2024-08-08D/A$51.3M$36.2M
2023-08-17D$40.2M$20.7M
2020-10-02D$15.0M$870K
2019-04-22D/A$15.0M$15.0M
2018-01-24D$15.0M$2.4M
2016-01-13D$2.5M$1.7M
2012-07-12D$571K$571K

More